Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Keith

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 20, 2012
Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosusMichael P Keith, Clovis Pitchford, Wendy B Bernstein
Autoimmunity Reviews|February 24, 2007
Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue diseaseMichael P Keith, Chantal Moratz, George C Tsokos
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 7, 2010
Refractory polyarticular gouty arthritis as a manifestation of immune reconstitution inflammatory syndromePeter J Sebeny, Michael P Keith, Kathleen M Love, et al.
Autoimmunity|April 25, 2007
Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) miceMichael P Keith, Chantal Moratz, Ryan Egan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 17, 2010
Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptidesLatisha D Heinlen, Lauren L Ritterhouse, Micah T McClain, et al.
Military Medicine|October 19, 2016
Anthrax Vaccine and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus in the U.S. Military: A Case-Control StudyBarbara H Bardenheier, Jonathan Duffy, Susan K Duderstadt, et al.
Plos One|March 13, 2010
60 kD Ro and nRNP A frequently initiate human lupus autoimmunityLatisha D Heinlen, Micah T McClain, Lauren L Ritterhouse, et al.
Journal of Autoimmunity|June 25, 2016
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodiesRufei Lu, Melissa E Munroe, Joel M Guthridge, et al.
Annals of the Rheumatic Diseases|April 19, 2016
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classificationMelissa E Munroe, Rufei Lu, Yan D Zhao, et al.
Lupus Science & Medicine|November 28, 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activityMelissa E Munroe, Kendra Young, Rufei Lu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 20, 2012
Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosusMichael P Keith, Clovis Pitchford, Wendy B Bernstein
Autoimmunity Reviews|February 24, 2007
Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue diseaseMichael P Keith, Chantal Moratz, George C Tsokos
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 7, 2010
Refractory polyarticular gouty arthritis as a manifestation of immune reconstitution inflammatory syndromePeter J Sebeny, Michael P Keith, Kathleen M Love, et al.
Autoimmunity|April 25, 2007
Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) miceMichael P Keith, Chantal Moratz, Ryan Egan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 17, 2010
Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptidesLatisha D Heinlen, Lauren L Ritterhouse, Micah T McClain, et al.
Military Medicine|October 19, 2016
Anthrax Vaccine and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus in the U.S. Military: A Case-Control StudyBarbara H Bardenheier, Jonathan Duffy, Susan K Duderstadt, et al.
Plos One|March 13, 2010
60 kD Ro and nRNP A frequently initiate human lupus autoimmunityLatisha D Heinlen, Micah T McClain, Lauren L Ritterhouse, et al.
Journal of Autoimmunity|June 25, 2016
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodiesRufei Lu, Melissa E Munroe, Joel M Guthridge, et al.
Annals of the Rheumatic Diseases|April 19, 2016
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classificationMelissa E Munroe, Rufei Lu, Yan D Zhao, et al.
Lupus Science & Medicine|November 28, 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activityMelissa E Munroe, Kendra Young, Rufei Lu, et al.
Pageof 2